Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registryJeffrey A Sparks, Zachary S Wallace, Andrea M Seet, Milena A Gianfrancesco, Zara Izadi, Kimme L Hyrich, Anja Strangfeld, Laure Gossec, Loreto Carmona, Elsa F Mateus, Saskia Lawson-Tovey, Laura Trupin, Stephanie Rush, Patricia Katz, Gabriela SchmajukSee the full list of authors
28 May 2021
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patientsKaterina Chavatza, Myrto Kostopoulou, Dionysis Nikolopoulos, Ourania Gioti, Konstantina Togia, Laura Andreoli, Martin Aringer, John Boletis, Andrea Doria, Frederic A Houssiau, David Jayne, Marta Mosca, Elisabet Svenungsson, Angela Tincani, George BertsiasSee the full list of authors
23 June 2021
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trialVeerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren
2 April 2021
Maintaining musculoskeletal health using a behavioural therapy approach: a population-based randomised controlled trial (the MAmMOTH Study)Gary J Macfarlane, Marcus Beasley, Neil Scott, Huey Chong, Paul McNamee, John McBeth, Neil Basu, Philip C Hannaford, Gareth T Jones, Phil Keeley, Gordon J Prescott, Karina Lovell
1 February 2021
Modern treatment approach results in low disease activity in 90% of pregnant rheumatoid arthritis patients: the PreCARA studyHieronymus TW Smeele, Esther Röder, Hetty M Wintjes, Laura JC Kranenburg-van Koppen, Johanna MW Hazes, Radboud JEM Dolhain
10 February 2021
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registryAnja Strangfeld, Martin Schäfer, Milena A Gianfrancesco, Saskia Lawson-Tovey, Jean W Liew, Lotta Ljung, Elsa F Mateus, Christophe Richez, Maria J Santos, Gabriela Schmajuk, Carlo A Scirè, Emily Sirotich, Jeffrey A Sparks, Paul Sufka, Thierry ThomasSee the full list of authors
27 January 2021
2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practiceValentin Ritschl, Tanja A Stamm, Daniel Aletaha, Johannes W J Bijlsma, Peter Böhm, Razvan Gabriel Dragoi, Emma Dures, Fernando Estévez-López, Laure Gossec, Annamaria Iagnocco, Andrea Marques, Ellen Moholt, Michal Nudel, Bart J F van den Bemt, Kirsten ViktilSee the full list of authors
18 December 2020
Non-surgical and surgical treatments for rotator cuff disease: a pragmatic randomised clinical trial with 2-year follow-up after initial rehabilitationSanna Cederqvist, Tapio Flinkkilä, Markus Sormaala, Jari Ylinen, Hannu Kautiainen, Tero Irmola, Heidi Lehtokangas, Juho Liukkonen, Konsta Pamilo, Tero Ridanpää, Kai Sirniö, Juhana Leppilahti, Ilkka Kiviranta, Juha Paloneva
3 December 2020
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitorsMarie Kostine, Axel Finckh, Clifton O Bingham, Karen Visser, Jan Leipe, Hendrik Schulze-Koops, Ernest H Choy, Karolina Benesova, Timothy R D J Radstake, Andrew P Cope, Olivier Lambotte, Jacques-Eric Gottenberg, Yves Allenbach, Marianne Visser, Cindy RusthovenSee the full list of authors
23 April 2020
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry studyDimitrios A Pappas, Gregory St John, Carol J Etzel, Stefano Fiore, Taylor Blachley, Toshio Kimura, Rajeshwari Punekar, Kelechi Emeanuru, Jeannie Choi, Susan Boklage, Joel M Kremer
21 July 2020
